Hemacare Corporation, A Charles River Company

Hemacare Corporation, A Charles River Company company information, Employees & Contact Information

ABOUT HEMCARE: HemaCare, a Charles River company, is a global leader in the supply and customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development. Through our network of collection centers with access to an extensive recallable and reliable donor network, we provide clients with the cellular material they need for the development of the next generation of cell and gene therapies – including fresh and cryopreserved starting material and isolated cellular material derived from peripheral blood, bone marrow, and cord blood. Combined with Charles River’s integrated, early-stage portfolio of discovery, safety assessment, and manufacturing support services, we provide customers comprehensive solutions from discovery through commercialization. To learn more about our portfolio and services, visit www.hemacare.com. HEMACARE'S MISSION: Providing a best-in-class portfolio of high quality, customizable human cellular material and services to support drug discovery, scientific research, and cell therapy. HEMACARE'S VISION: Advancing drug discovery, scientific research, and cell therapy with the highest quality human cells.

Company Details

Employees
92
Founded
-
Address
8500 Balboa Boulevard,
Phone
(877) 310-0717
Email
ma****@****are.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Northridge, CA
Looking for a particular Hemacare Corporation, A Charles River Company employee's phone or email?

Hemacare Corporation, A Charles River Company Questions

News

HemaCare Expands Its Offering of Stem Cell-Enriched Peripheral Blood - BioInformant

HemaCare Expands Its Offering of Stem Cell-Enriched Peripheral Blood BioInformant

Charles River: COVID forces closure of donor clinic disrupting HemaCare biz - BioProcess International

Charles River: COVID forces closure of donor clinic disrupting HemaCare biz BioProcess International

MicroMedicine and HemaCare Announce Cooperative Efforts to Improve Cell Therapy Starting Materials - PR Newswire

MicroMedicine and HemaCare Announce Cooperative Efforts to Improve Cell Therapy Starting Materials PR Newswire

Charles River Labs to buy HemaCare for $380M, expanding in cell therapy - BioPharma Dive

Charles River Labs to buy HemaCare for $380M, expanding in cell therapy BioPharma Dive

In vitro veritas: Biosensors and microarrays come to life - Science | AAAS

In vitro veritas: Biosensors and microarrays come to life Science | AAAS

Charles River Labs to Acquire HemaCare for $380M, Expanding Presence in Cell Therapy - Genetic Engineering and Biotechnology News

Charles River Labs to Acquire HemaCare for $380M, Expanding Presence in Cell Therapy Genetic Engineering and Biotechnology News

Charles River taps HemaCare’s PBMC for humanized mouse models - Fierce Biotech

Charles River taps HemaCare’s PBMC for humanized mouse models Fierce Biotech

The Evolving Role of Starting Materials in Cell and Gene Therapy - BioPharm International

The Evolving Role of Starting Materials in Cell and Gene Therapy BioPharm International

Why is Healthy Donor Tissue So Important for Cell and Gene Therapies? - BioInformant

Why is Healthy Donor Tissue So Important for Cell and Gene Therapies? BioInformant

HemaCare provides human derived biological material to China - BioSpectrum Asia

HemaCare provides human derived biological material to China BioSpectrum Asia

Charles River Laboratories Completes Acquisition of HemaCare for $380 Million Cash - BioInformant

Charles River Laboratories Completes Acquisition of HemaCare for $380 Million Cash BioInformant

HemaCare Provides Starting Material for All Three FDA Approved Immunotherapies - BioInformant

HemaCare Provides Starting Material for All Three FDA Approved Immunotherapies BioInformant

San Antonio healthcare services organization launches first-in-the-world mobile leukapheresis center supporting cell and gene therapies - BioInformant

San Antonio healthcare services organization launches first-in-the-world mobile leukapheresis center supporting cell and gene therapies BioInformant

Top Hemacare Corporation, A Charles River Company Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant